AbbVie Dumps An Early-Alzheimer’s Candidate Developing In Collaboration With Alector
AbbVie Inc (NYSE:ABBV) has decided to terminate the CD33 collaboration program with Alector Inc (NASDAQ:ALEC), developing AL003 for Alzheimer’s disease as one of…